Latest News

Fosun Pharma Announces 2024Q3 Financial Results

Revenue Exceed RMB30.9 Billion with R&D Expenditure RMB3.9 Billion Continuing to Consolidate its Dominant Position In The fields of Breast Cancer and Lung Cancer SHANGHAI, Oct. 29, 2024 /PRNewswire/ -- On October 29, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma" or "the Group";...

2024-10-30 10:41 3573

WuXi AppTec Named Global CRDMO Company of the Year by Frost & Sullivan for the Eighth Consecutive Year

SHANGHAI, Oct. 29, 2024 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, has been awarded the 2024 Global CRDMO Company of the Year Award by Frost & Sullivan, a gr...

2024-10-30 08:00 3001

The Basque Country and Japan, 'connected' and 'like-minded' wine markets

TOKYO, Oct. 30, 2024 /PRNewswire/ -- A total of 22 wineries producing Rioja Alavesa D.O. wines, Txakoli, and Basque cider introduced their products to the Japanese market with support from the Basque government, highlighting the affinity and connection between the Basque Country and the Asian nat...

2024-10-30 07:00 2659

Boqii Filed Annual Report on Form 20F for Fiscal Year 2024

SHANGHAI, Oct. 29, 2024 /PRNewswire/ -- Boqii Holding Limited ("Boqii" or the "Company") (NYSE: BQ), a leading pet-focused platform inChina, today announced that it filed its annual report on Form 20-F (the "Annual Report") for the fiscal year endedMarch 31, 2024 with the U.S. Securities and Exch...

2024-10-30 05:00 3078

Celltrion presents post hoc analysis of LIBERTY studies of ZYMFENTRA®  (infliximab-dyyb) at the American College of Gastroenterology 2024 Annual Scientific Meeting

* Pivotal LIBERTY studies (LIBERTY-CD and LIBERTY-UC) previously demonstrated superior efficacy of subcutaneous (SC) infliximab over placebo for maintenance therapy in patients with Crohn's disease (CD) and ulcerative colitis (UC)[1], [2] * ZYMFENTRA® is the first and only FDA-approved subcut...

2024-10-30 03:25 2747

I Peace announces new iPSC lines to reduce immune rejection risk for U.S. population

More than 100 million people in the US have this HLA-A haplotype PALO ALTO, Calif., Oct. 29, 2024 /PRNewswire/ -- Leading GMP cell CDMO I Peace, Inc. (https://www.ipeace.com ), specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies, announ...

2024-10-30 02:55 2221

VIVOTEK's All-in-One "Device Manager" Software Boosts Operational Efficiency for Enterprises

Manage thousands of cameras remotely with real-time alerts and updates, with no need for on-site visits TAIPEI, Oct. 29, 2024 /PRNewswire/ -- As demand for high-efficiency security systems rises among large enterprises, the global leading security solution provider VIVOTEK (3454-TW) introduces n...

2024-10-29 23:00 3769

LILYSILK Continues Partnership with National Breast Cancer Foundation for Breast Cancer Awareness Month

NEW YORK, Oct. 29, 2024 /PRNewswire/ -- LILYSILK , the world's leading silk brand with a mission to inspire people to live better, sustainable lives, proudly continues its collaboration withNational Breast Canc...

2024-10-29 22:00 2296

Aetherium Acquisition Corp. Receives Letter of Termination of Business Combination Agreement

GREENWICH, Conn., Oct. 29, 2024 /PRNewswire/ -- Aetherium Acquisition Corp. (Nasdaq: GMFI) ("Aetherium" or "Company") announced today that it received written notice from Capital A Berhad stating that it has elected to unilaterally terminate the business combination agreement datedFebruary 28, 20...

2024-10-29 21:13 2657

Complete Genomics integrates NVIDIA Parabricks to offer researchers faster, more cost-effective and accurate genomic sequencing analysis

Complete Genomics DNBSEQ data and NVIDIA Parabricks yield deeper insights into genetic variants with deep learning SAN JOSE, Calif., Oct. 29, 2024 /PRNewswire/ -- Complete Genomics today announced an integration of its next-generation sequencing (NGS) DNBSEQ platforms* with NVIDIA Parabricks sof...

2024-10-29 21:00 1996

DeepQure Presents Clinical Results of Laparoscopic RDN at TCT 2024, Demonstrating Cutting-edge Technology and Innovation

SEOUL, South Korea, Oct. 29, 2024 /PRNewswire/ -- DeepQure, a global pioneer in resistant hypertension treatment, has unveiled clinical results of its laparoscopic renal denervation (RDN) medical device "HyperQure". Designed to treat resistant hypertension,HyperQure uses a laparoscopic approach t...

2024-10-29 21:00 3297

Bloomage Presents Research on Fermented Brown Rice Filtrate's Impact on Skin Microbiome at 2024 IFSCC Main Podium

PARSIPPANY, N.J., Oct. 29, 2024 /PRNewswire/ -- Bloomage (SHA: 688363), a leader in hyaluronic acid and other bioactive substance innovations, attended the International Federation of Societies of Cosmetic Chemists (IFSCC) Congress 2024, held betweenOct. 15 to 17 in Foz do Iguaçu, to present its ...

2024-10-29 21:00 2075

Popilush Launches TikTok Shop Super Brand Day in the US

NEW YORK, Oct. 29, 2024 /PRNewswire/ -- Popilush, a leading name in the fashion shapewear industry, kicked off its TikTok Shop Super Brand Day with an exclusive event titled "Party with Popilush." The event took place at Popilush's new office inNew York, bringing together long-term partners, cont...

2024-10-29 21:00 2537

Qilian International Holding Group Limited Announces Name Change to BGM Group Ltd.

CHENGDU, China, Oct. 29, 2024 /PRNewswire/ -- Qilian International Holding Group Ltd. ("Qilian" or the "Company") (NASDAQ: BGM) is pleased to announce that effective onOctober 30, 2024, the Company will change its name to "BGM Group Ltd." In connection with the name change, the trading symbol of ...

2024-10-29 20:00 3703

Chengdu's Wuhou district sets ambitious course for music industry

CHENGDU, China, Oct. 29, 2024 /PRNewswire/ -- Wuhou district in Chengdu, Sichuan province held a promotional event inBeijing on Oct 28 to advance the high-quality development of its music and cultural innovation industries.

2024-10-29 18:48 2530

"Green Electricity Ark" Debuts at COP16: Showcasing Innovative Solutions for Biodiversity Conservation by China's State-Owned Enterprises

CALI, Colombia, Oct. 29, 2024 /PRNewswire/ -- On October 21, the 16th meeting of the Conference of the Parties to the United Nations Convention on Biological Diversity(COP16) opened successfully in Cali, Colombia. On October 24, the themed side event "Innovative Solutions for Biodiversity Mainstr...

2024-10-29 17:39 2550

For 12 years, what has the Shenzhen International Low Carbon City Forum told the world?

SHENZHEN, China, Oct. 29, 2024 /PRNewswire/ -- On October 28, the 12th session of the Shenzhen International Low Carbon City Forum was opened successfully. "Shenzhen, international and low-carbon" - for 12 years, the forum has been talking about stories of going green. It is a story of forerunne...

2024-10-29 17:28 2837

Dujiangyan explores business potential of giant pandas

CHENGDU, China, Oct. 29, 2024 /PRNewswire/ -- During International Giant Panda Day on Oct 27, Dujiangyan city inSichuan province announced its participation in the Panda Homeland Culture Creativity Contest. Hosted by theChengdu government, it aims to helpChengdu emerge as a leading global center ...

2024-10-29 17:25 2326

Weibo Corporation to Report Third Quarter 2024 Financial Results on November 19, 2024

BEIJING, Oct. 29, 2024 /PRNewswire/ -- Weibo Corporation (Nasdaq: WB and HKEX: 9898), a leading social media for people to create, share and discover content, will announce its unaudited financial results for the third quarter 2024 before the U.S. market opens onTuesday, November 19, 2024. Follow...

2024-10-29 17:00 3149

FinVolution Subsidiary AdaKami Enters into Strategic Funding Agreement with PT Super Bank, Indonesia

SHANGHAI, Oct. 29, 2024 /PRNewswire/ -- FinVolution Group ("FinVolution," or the "Company") (NYSE: FINV), a leading fintech platform, today announced that its Indonesian financial application, AdaKami, has entered into a strategic funding agreement with PT Super Bank Indonesia, a leading digital-...

2024-10-29 16:30 3672